1. Adrenal suppression by oral high dose medroxyprogesterone acetate in breast cancer patients;H, Van Veelan; PH, Willemse; DT, Sleijfer; JJ, Pratt; WJ, Sluiter; H, Doorenbos;Cancer Chemother Pharmnacol,1984
2. Endocrinological properties of medroxyprogesterone acetate;Sala, G.; lannotta F; Facchinetti, A.,1982
3. Effects of medroxyprogesterone acetate on some healthy male volunteers;Novak, E.; Hendrix, J.W.; Seckman, C.E.;Current Therapeutic Research,1977
4. Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer;Nemoto, T.; Patel, J.; Rosner, D.; Dao, T.L.;J Surg Oncol,1986
5. The Cushing syndrome induced by medroxyprogesterone acetate;Siminoski, K.; Goss, P.; Drucker, D.J.;Ann Intern Med,1989